Understanding how Notch signaling affects pancreatic cancer's environment.
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.
This study is looking at how a specific signaling process in pancreatic cancer affects the immune system's ability to fight the disease, with the hope of finding new ways to make current treatments work better for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11061908 on NIH RePORTER |
What this research studies
This research investigates the role of Notch signaling in the pancreatic cancer microenvironment, which is known to suppress the immune response and contribute to treatment resistance. By examining how Notch influences the behavior of immune cells within tumors, the study aims to uncover mechanisms that lead to the establishment of an immunosuppressive environment. The research will involve laboratory assays and biological analyses to explore the interactions between Notch signaling and immune cell polarization. Ultimately, the goal is to identify new strategies to enhance the effectiveness of existing cancer therapies, including immunotherapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic cancer who may benefit from enhanced immunotherapy approaches.
Not a fit: Patients with non-cancerous conditions or those with pancreatic cancer that has progressed beyond treatment options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for pancreatic cancer patients by overcoming immune suppression.
How similar studies have performed: Previous research has shown promising results in targeting signaling pathways like Notch to improve cancer treatment outcomes, suggesting this approach may be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Pasca Di Magliano, Marina — University of Michigan at Ann Arbor
- Study coordinator: Pasca Di Magliano, Marina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.